Novartis AG Reduction Of Issued Capital
Novartis AG (NVSEF) had Reduction Of Issued Capital of $17.10 million as of 2023-09-15, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:ReductionOfIssuedCapital · last filed 2026-02-04
- Novartis AG reduction of issued capital for the quarter ending 2019-06-30 was $0.00.
- Novartis AG reduction of issued capital for the quarter ending 2018-06-30 was $0.00.
USD
| Period end | Reduction Of Issued Capital | Reduction Of Issued Capital 3 month | Reduction Of Issued Capital 6 month |
|---|---|---|---|
| 2023-09-15 | $17.10M 20-F · filed 2026-02-04 | ||
| 2019-06-30 | $0.00 6-K · filed 2019-07-18 | $0.00 6-K · filed 2019-07-18 | |
| 2018-06-30 | $0.00 6-K · filed 2019-07-18 | $0.00 6-K · filed 2019-07-18 |
CHF
| Period end | Reduction Of Issued Capital |
|---|---|
| 2023-09-15 | 22.80M CHF 20-F · filed 2026-02-04 |